LifeStance Health Group (LFST) to Release Quarterly Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) is set to issue its quarterly earnings data before the market opens on Thursday, August 8th. Analysts expect LifeStance Health Group to post earnings of ($0.07) per share for the quarter. LifeStance Health Group has set its FY 2024 guidance at EPS and its Q2 2024 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, May 9th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.03. The business had revenue of $300.44 million during the quarter, compared to the consensus estimate of $299.02 million. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The business’s quarterly revenue was up 18.9% on a year-over-year basis. During the same period in the previous year, the business earned ($0.09) EPS. On average, analysts expect LifeStance Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeStance Health Group Trading Up 0.7 %

NASDAQ:LFST opened at $5.55 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.20. LifeStance Health Group has a 52-week low of $4.64 and a 52-week high of $9.20. The stock’s 50 day moving average price is $5.38 and its 200 day moving average price is $6.11. The company has a market capitalization of $2.12 billion, a PE ratio of -11.56 and a beta of 1.20.

Analysts Set New Price Targets

Separately, Morgan Stanley reiterated an “overweight” rating and issued a $10.00 price target on shares of LifeStance Health Group in a research report on Monday, April 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $8.80.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Paula Cipollone sold 48,278 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $7.22, for a total transaction of $348,567.16. Following the transaction, the insider now directly owns 239,915 shares in the company, valued at $1,732,186.30. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Paula Cipollone sold 48,278 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $7.22, for a total transaction of $348,567.16. Following the transaction, the insider now owns 239,915 shares of the company’s stock, valued at $1,732,186.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the stock in a transaction on Friday, May 24th. The stock was sold at an average price of $5.89, for a total value of $22,395,812.05. Following the completion of the transaction, the insider now owns 41,932,358 shares of the company’s stock, valued at approximately $246,981,588.62. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,087,716 shares of company stock valued at $24,010,444. 6.60% of the stock is owned by company insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.